Extracorporeal CO2 removal (ECCO2R) in patients with stable COPD with chronic hypercapnia: a proof-of-concept study

Thorax. 2020 Oct;75(10):897-900. doi: 10.1136/thoraxjnl-2020-214744. Epub 2020 Aug 5.

Abstract

Domiciliary non-invasive ventilation (NIV) effectively reduces arterial carbon dioxide pressure (PaCO2) in patients with stable hypercapnic chronic obstructive pulmonary disease, but a consistent percentage of them may remain hypercapnic. We hypothesised that extracorporeal CO2 removal (ECCO2R) may lower their PaCO2 Ten patients hypercapnic despite ≥6 months of NIV underwent a 24-hour trial of ECCO2R. Six patients completed the ECCO2R-trial with a PaCO2 drop ranging between 23% and 47%. Time to return to baseline after interruption ranged 48-96 hours. In four patients, mechanical events led to ECCO2R premature interruption, despite a decreased in PaCO2 This time window 'free' from hypercapnia might allow to propose the concept of 'CO2 dialysis'.

Keywords: COPD ÀÜ mechanisms; critical care; non invasive ventilation.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Carbon Dioxide
  • Chronic Disease
  • Female
  • Humans
  • Hypercapnia / diagnosis
  • Hypercapnia / etiology
  • Hypercapnia / therapy*
  • Male
  • Middle Aged
  • Noninvasive Ventilation / methods*
  • Proof of Concept Study
  • Pulmonary Disease, Chronic Obstructive / complications*
  • Pulmonary Disease, Chronic Obstructive / therapy*

Substances

  • Carbon Dioxide